Dr Reddy's Laboratories net profit rises 45% to Rs 663 cr in June quarter; revenue up 3.3%
Dr Reddy's Laboratories on Monday posted a 45.31 percent rise in consolidated net profit at Rs 662.8 crore for the June quarter


Representational image. Getty.[/caption]"This quarter, we grew in most of our key markets and hope to continue this momentum with a sharper focus on performance," Dr Reddy's Laboratories Chief Executive Officer (CEO) and Co-Chairman G V Prasad said.The Hyderabad-based firm said that with effect from 1 August, Erez Israeli will be elevated as the CEO of the company.Prasad will continue as the co-chairman and managing director, and Israeli will continue to report to him, it added.Since joining the company as the chief operating officer in April 2018, Israeli has spearheaded the transformation agenda of the organisation by ensuring clear focus and strategy, setting foundations for sustainable financial growth and leading business delivery, the drug firm said.His appointment as the CEO will help propel the organisation's growth agenda forward, it added.Shares of Dr Reddy's ended 1.92 percent down at Rs 2,652.55 apiece on the BSE.

India remains among fastest-growing major economies despite global uncertainty, says RBI Bulletin
Iran war could cut global growth by more than half: World Bank’s chief economist Indermit Gill
Brent crude climbs to $94 as analysts expect oil prices to stay in $90–100 range
UK inflation cools further to 2.6% in June as transport and food prices ease
India's gem and jewellery exports jump 26.5% in June on stronger global demand

